Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Torres

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
American Journal of Hematology|June 15, 2026
Promoter TERT-Related Hematopoietic Somatic Mosaicism in Patients With Telomere Biology DisordersMadeline Franke, Rachel Kirchner, Bianca Barredo, et al.
Genes|January 27, 2021
<i>BARD1</i> Pathogenic Variants are Associated with Triple-Negative Breast Cancer in a Spanish Hereditary Breast and Ovarian Cancer CohortPaula Rofes, Jesús Del Valle, Sara Torres-Esquius, et al.
Blood Advances|April 9, 2026
Performance and Clinical Utility of Spanish Germline Genetic Testing Criteria for Hematologic Neoplasms PredispositionSara Torres-Esquius, Guillermo Ramil, Maria Gabarrós-Subirà, et al.
Journal of Medical Genetics|November 29, 2022
Clinical and psychological implications of secondary and incidental findings in cancer susceptibility genes after exome sequencing in patients with rare disordersEstela Carrasco, Adrià López-Fernández, Marta Codina-Sola, et al.
British Journal of Haematology|April 19, 2024
Germline assessment for alloHSCT candidates over 50 years: A 'Fast-Track' screening in myeloid neoplasmsSara Torres-Esquius, Francisco Beas, Tzu Hua Chen-Liang, et al.
The Journal of Investigative Dermatology|August 30, 2019
Low SATB1 Expression Promotes IL-5 and IL-9 Expression in Sézary SyndromeAlberto Herrera, Simon Fredholm, Anthony Cheng, et al.
Leukemia|May 7, 2025
Myelodysplastic neoplasms with ring sideroblasts without SF3B1 mutations in adults: enrichment of germline variants in congenital sideroblastic anemia genesSandra Novoa-Jáuregui, Sandra Huber, Maria Gabarrós-Subirà, et al.
NPJ Breast Cancer|March 5, 2026
RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancerAlba Llop-Guevara, Benedetta Pellegrino, Isabel Pimentel, et al.
JAMA Network Open|April 22, 2024
Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian CancerSara Torres-Esquius, Alba Llop-Guevara, Sara Gutiérrez-Enríquez, et al.
Leukemia|December 3, 2025
DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective studyCarmelo Gurnari, Hideki Makishima, Arda Durmaz, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
American Journal of Hematology|June 15, 2026
Promoter TERT-Related Hematopoietic Somatic Mosaicism in Patients With Telomere Biology DisordersMadeline Franke, Rachel Kirchner, Bianca Barredo, et al.
Genes|January 27, 2021
<i>BARD1</i> Pathogenic Variants are Associated with Triple-Negative Breast Cancer in a Spanish Hereditary Breast and Ovarian Cancer CohortPaula Rofes, Jesús Del Valle, Sara Torres-Esquius, et al.
Blood Advances|April 9, 2026
Performance and Clinical Utility of Spanish Germline Genetic Testing Criteria for Hematologic Neoplasms PredispositionSara Torres-Esquius, Guillermo Ramil, Maria Gabarrós-Subirà, et al.
Journal of Medical Genetics|November 29, 2022
Clinical and psychological implications of secondary and incidental findings in cancer susceptibility genes after exome sequencing in patients with rare disordersEstela Carrasco, Adrià López-Fernández, Marta Codina-Sola, et al.
British Journal of Haematology|April 19, 2024
Germline assessment for alloHSCT candidates over 50 years: A 'Fast-Track' screening in myeloid neoplasmsSara Torres-Esquius, Francisco Beas, Tzu Hua Chen-Liang, et al.
The Journal of Investigative Dermatology|August 30, 2019
Low SATB1 Expression Promotes IL-5 and IL-9 Expression in Sézary SyndromeAlberto Herrera, Simon Fredholm, Anthony Cheng, et al.
Leukemia|May 7, 2025
Myelodysplastic neoplasms with ring sideroblasts without SF3B1 mutations in adults: enrichment of germline variants in congenital sideroblastic anemia genesSandra Novoa-Jáuregui, Sandra Huber, Maria Gabarrós-Subirà, et al.
NPJ Breast Cancer|March 5, 2026
RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancerAlba Llop-Guevara, Benedetta Pellegrino, Isabel Pimentel, et al.
JAMA Network Open|April 22, 2024
Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian CancerSara Torres-Esquius, Alba Llop-Guevara, Sara Gutiérrez-Enríquez, et al.
Leukemia|December 3, 2025
DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective studyCarmelo Gurnari, Hideki Makishima, Arda Durmaz, et al.
Pageof 9